Table 1

Demographic data of subjects recruited in this study

Characteristics

Active SLE Group

Inactive SLE Group

Psoriasis Group

Control Group


Numbers

13

16

5

10

Sex, female:male

12:1

16:0

3:2

10:0

Age, years

15 to 50

17 to 50

39 to 61

24 to 28

(mean ± S.D.)

(34.62 ± 11.46)

(33 ± 11.16)

(51 ± 9.88)

(25.6 ± 1.58)

SLEDAI score

≥ 6

< 6

-

-

(mean ± S.D.)

(12.92 ± 7.83)

(2.56 ± 2.03)

Range of PASI score

11.2 to 27

(mean ± S.D.)

-

-

(18.02 ± 5.38)

-

Treatment (mg/day)

(mean ± S.D.)

Prednisolone

13.13 ± 10.06

9.38 ± 8.45

-

-

Cyclophosphamide

-

25

-

-

Azathioprine

50 ± 30.62

47.5 ± 33.54

-

-

Mycophenolate mofetil

1,250

-

-

-

Methotrexate

-

-

6.43


Puwipirom et al. Arthritis Research & Therapy 2010 12:R215   doi:10.1186/ar3194

Open Data